Low-FODMAP, medication, or hypnotherapy? Comparing every major IBS treatment and what the evidence actually says

Living with irritable bowel syndrome often means living in a state of permanent experimentation. Try this diet. Try that supplement. Take this pill for six weeks and see what happens. For the estimated 1 in 10 people worldwide who have IBS, treatment can feel like a process of elimination in every sense.

The problem isn't a lack of options. It's that patients and even clinicians rarely see those options compared side by side. What does the evidence actually say about each major IBS treatment? Which ones provide lasting relief, and which ones merely manage symptoms? What are the trade-offs?

We reviewed the clinical literature and spoke to gastroenterologists and GI researchers to build a clear, evidence-based comparison.

Low-FODMAP diet

What it is: A structured elimination diet developed by researchers at Monash University that restricts fermentable carbohydrates (certain sugars found in foods like onions, garlic, wheat, dairy, and some fruits).

How well it works: The evidence is solid for short-term symptom improvement. A 2022 meta-analysis in the Journal of Gastroenterology and Hepatology found that 52 to 76% of IBS patients experience symptom improvement on a strict low-FODMAP diet. However, the diet is meant to be temporary. Patients eliminate high-FODMAP foods, then systematically reintroduce them to identify personal triggers.

The trade-offs: It's extremely difficult to follow. It requires significant dietary knowledge, meal planning, and social adjustment. Long-term adherence is poor: studies show most patients drift from the protocol within 6 to 12 months. There are also concerns about nutritional adequacy. A strict low-FODMAP diet can reduce intake of prebiotic fiber, potentially harming the gut microbiome over time. A 2023 study in Gut found that prolonged FODMAP restriction reduced beneficial Bifidobacteria populations.

Dietitian support is essentially mandatory, adding cost and access barriers.

Bottom line: Effective as a short-term diagnostic tool. Less effective as a long-term management strategy.

Antispasmodic medications

What they are: Drugs like hyoscine butylbromide (Buscopan), mebeverine, and peppermint oil capsules that target smooth muscle spasms in the gut.

How well they work: Modestly. A Cochrane review of antispasmodics for IBS found a number needed to treat (NNT) of 5, meaning you'd need to treat five patients for one to experience meaningful benefit beyond placebo. They work best for cramping and pain-dominant IBS, less so for bloating, diarrhea, or constipation.

The trade-offs: Side effects include dry mouth, constipation, blurred vision, and urinary retention. They address symptoms only. They do nothing to modify the underlying gut-brain dysfunction that drives IBS. Effectiveness tends to plateau or diminish over time.

Bottom line: Useful for acute flare-ups. Not a long-term solution.

Antidepressants (tricyclics and SSRIs)

What they are: Low-dose tricyclic antidepressants (amitriptyline, nortriptyline) or SSRIs (citalopram, fluoxetine) prescribed off-label to modulate gut-brain signaling and reduce visceral pain.

How well they work: Better than antispasmodics. The ATLANTIS trial, published in The Lancet in 2023, was the largest RCT of low-dose amitriptyline for IBS and found significant improvements in symptom severity. The NNT was approximately 4.5. SSRIs show similar effect sizes in meta-analyses, with particular benefit for patients with concurrent anxiety or depression.

The trade-offs: Side effects are common and can be deal-breakers: drowsiness, dry mouth, weight gain, sexual dysfunction, and constipation (tricyclics) or diarrhea (SSRIs). Patients often resist taking antidepressants for a "gut condition," and there's a withdrawal process when discontinuing. The effects are also purely symptomatic. Stop the medication, and symptoms typically return.

Bottom line: Effective for pain-dominant IBS, especially with psychological comorbidity. Requires ongoing use and has meaningful side effects.

Probiotics

What they are: Live bacterial supplements intended to improve gut microbiome composition.

How well they work: Inconsistently. The evidence is a patchwork. Some specific strains, like Bifidobacterium infantis 35624, have shown benefit in well-designed trials. But most commercial probiotics have little to no evidence behind them. A 2024 systematic review in Alimentary Pharmacology & Therapeutics concluded that while certain multi-strain formulations showed modest benefit for bloating, the overall evidence for probiotics in IBS was "low to very low certainty."

The trade-offs: The probiotic market is essentially unregulated. Products vary wildly in quality, viability, and strain composition. Most commercial formulations haven't been tested in IBS-specific trials. Patients often spend significant money cycling through products that have no evidence base.

Bottom line: A few specific strains may help. Most products on the market are hope in a capsule.

Gut-directed hypnotherapy

What it is: A structured psychological therapy in which a trained clinician uses hypnotic suggestion and guided imagery to target gut function, modulate visceral sensitivity, and retrain the gut-brain communication loop.

How well it works: The evidence base is arguably the strongest of any IBS treatment for sustained outcomes. The Manchester Protocol, developed by Professor Peter Whorwell over four decades of research, has been validated in multiple RCTs. A 2023 Lancet Gastroenterology & Hepatology systematic review found gut-directed hypnotherapy had the largest effect size of any psychological therapy studied for IBS. Recent trials show 70% or more of patients achieving clinically meaningful improvement, with effects sustained at 12-month follow-up.

Dr. Olafur Palsson at the University of North Carolina has published fMRI data showing that gut-directed hypnotherapy produces measurable changes in how the brain processes visceral signals, reducing pain processing in the anterior cingulate cortex and normalizing autonomic nervous system regulation.

The trade-offs: Access is the primary barrier. Trained GI hypnotherapists are scarce, and treatment typically requires 6 to 8 sessions. It's now available through digital platforms and apps, which broadens access but may not be suitable for patients with severe symptoms or trauma histories. It also requires patient willingness to engage with a form of therapy that many initially find unfamiliar.

Bottom line: Best-in-class evidence for lasting relief. No side effects. Addresses the root mechanism. Limited primarily by access and awareness.

The comparison at a glance

When you lay these options side by side, a pattern emerges. Most IBS treatments are symptom-management tools. They suppress or mask the signals without changing the underlying dysfunction. The low-FODMAP diet avoids triggers. Antispasmodics calm spasms. Antidepressants dampen nerve signaling. Probiotics attempt to shift the microbial environment.

Gut-directed hypnotherapy is the only intervention that directly targets the gut-brain communication loop itself, the visceral hypersensitivity and central nervous system dysregulation that drives IBS symptoms.

"If you only treat the gut, you're treating half the disease," said Dr. Magnus Simrén, professor of gastroenterology at the University of Gothenburg and a leading researcher in functional GI disorders. "IBS is a disorder of gut-brain interaction. The treatments that work best are the ones that address both ends of that axis."

That doesn't mean gut-directed hypnotherapy is the right choice for every patient. Some people respond well to dietary changes. Others need the immediate relief that medication provides. The optimal approach may be a combination: using dietary strategies for trigger management while hypnotherapy retrains the underlying nervous system dysfunction.

But for the millions of IBS patients who have tried everything and found only partial relief, the evidence suggests they may simply have been offered the wrong category of treatment. The strongest tool in the evidence base is also the one most patients have never heard of.

What this comparison leaves most readers asking is whether gut-directed hypnotherapy could actually resolve their IBS. The honest answer is: it depends on the type of IBS you have and what's driving it. Patients whose symptoms are primarily rooted in gut-brain miscommunication tend to respond remarkably well. Those with other contributing factors may need a combined approach. The problem is that most patients have never been assessed for that distinction, which means they've been choosing treatments without knowing the one piece of information that matters most.